Deutsche Bank AG Buys New Holdings in Establishment Labs Holdings Inc. $ESTA

Key Points

• Deutsche Bank acquired 128,138 shares of Establishment Labs in the second quarter, worth approximately $11 million and representing 0.44% of the company. Institutional investors collectively own 72.91% of ESTA.
• Establishment Labs reported quarterly revenue of $67.54 million, up 31.7% year over year and above estimates, but its loss of $0.39 per share was wider than expected.
• Analyst sentiment remains favorable: eight analysts rate the stock a Buy and one rates it a Sell, producing a “Moderate Buy” consensus and an average price target of $100.25 versus a recent price of $72.67.

Deutsche Bank AG purchased a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 128,138 shares of the company's stock, valued at approximately $10,996,000. Deutsche Bank AG owned 0.44% of Establishment Labs as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Rice Hall James & Associates LLC acquired a new stake in shares of Establishment Labs in the second quarter valued at approximately $48,134,000. Bank of New York Mellon Corp bought a new position in shares of Establishment Labs during the 2nd quarter worth approximately $5,848,000. State of Wyoming acquired a new position in shares of Establishment Labs during the 2nd quarter worth approximately $87,000. GSA Capital Partners LLP acquired a new position in shares of Establishment Labs during the 2nd quarter worth approximately $541,000. Finally, Handelsbanken Fonder AB raised its stake in Establishment Labs by 11.4% in the 2nd quarter. Handelsbanken Fonder AB now owns 9,800 shares of the company's stock valued at $841,000 after acquiring an additional 1,000 shares during the period. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Price Performance

Shares of NASDAQ ESTA opened at $72.67 on Monday. The firm has a market cap of $2.17 billion, a P/E ratio of -55.47 and a beta of 1.07. The company has a current ratio of 3.84, a quick ratio of 2.52 and a debt-to-equity ratio of 12.11. Establishment Labs Holdings Inc. has a 1-year low of $36.53 and a 1-year high of $97.59. The business's 50 day moving average is $86.19 and its 200-day moving average is $74.86.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.05). The firm had revenue of $67.54 million for the quarter, compared to the consensus estimate of $65.79 million. Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The firm's quarterly revenue was up 31.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.57) EPS. Equities research analysts predict that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current year.

Analyst Ratings Changes

ESTA has been the subject of several research reports. JPMorgan Chase & Co. raised their price target on Establishment Labs from $84.00 to $95.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Citigroup upgraded shares of Establishment Labs from a "neutral" rating to a "buy" rating and set a $92.00 price objective on the stock in a report on Thursday, August 13th. TD Cowen upped their price objective on shares of Establishment Labs from $95.00 to $117.00 and gave the company a "buy" rating in a report on Monday, August 3rd. BTIG Research increased their price objective on shares of Establishment Labs from $96.00 to $103.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Finally, Canaccord Genuity Group set a $105.00 target price on shares of Establishment Labs in a research note on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $100.25.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company's proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company's flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.

Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source